Genetics
Review: Tuberous sclerosis complex for the pulmonologist.
5 Aug, 2021 | 08:30h | UTCTuberous sclerosis complex for the pulmonologist – European Respiratory Review
Large genomic analysis has identified 13 new genomic regions associated with susceptibility and severity to Covid-19.
13 Jul, 2021 | 09:59h | UTCMapping the human genetic architecture of COVID-19 – Nature
Commentaries: The quest to find genes that drive severe COVID – Nature AND Gene hunters turn up new clues to help explain why Covid-19 hits some people so hard – STAT AND Large genomic analysis highlights COVID-19 risk factors – Broad Institute of MIT and Harvard AND A new study finds genetic variations in Covid patients that could point to better drug treatments. – The New York Times AND How your DNA may affect whether you get COVID-19 or become gravely ill – ScienceNews
WHO issues new recommendations on human genome editing for the advancement of public health.
13 Jul, 2021 | 09:42h | UTCSee reports:
Human genome editing: recommendations
Human genome editing: a framework for governance
Commentaries: New Global Recommendations for Human Genome Editing may Improve Use to Cure and Treat Diseases – Health Policy Watch AND WHO should lead on genome-editing policy, advisers say – Nature AND WHO Calls for Global Registry of Human Genome Editing – HealthDay AND Expert reaction to the WHO’s newly published recommendations and governance framework for human genome editing – Science Media Centre
Commentary on Twitter (thread – click for more)
Two ? reports provide the first global recommendations to help establish human genome ? editing as a tool for public health, with an emphasis on safety, effectiveness and ethics.
? https://t.co/w32QhMXSXi pic.twitter.com/Bto9SF6NzW
— World Health Organization (WHO) (@WHO) July 12, 2021
Review: Advances in the diagnosis and treatment of primary ciliary dyskinesia.
21 Jun, 2021 | 08:27h | UTCAdvances in the Diagnosis and Treatment of Primary Ciliary Dyskinesia: A Review – JAMA Otolaryngology – Head & Neck Surgery (free for a limited period)
CDC now calls coronavirus Delta variant a ‘variant of concern’.
17 Jun, 2021 | 09:53h | UTCCDC now calls coronavirus Delta variant a ‘variant of concern’ – CNN
Guidance: SARS-CoV-2 Variant Classifications and Definitions – Centers for Disease Control and Prevention
Commentary on Twitter
BREAKING—CDC now officially declares #DeltaVariant a “variant of concern”—because much more transmissible (50% faster than #B117, 2x than original strain), more severe (2.5x hospitalization risk than B117, 4x original) & 1 dose vaccine evasive.? #COVID19https://t.co/jZCgfzFLla pic.twitter.com/SszvXuysze
— Eric Feigl-Ding (@DrEricDing) June 15, 2021
[Preprint] Covid-19 B.1.617.2 variant of concern (Delta) is associated with increased transmissibility compared to B.1.1.7 (Alpha) that will rapidly lead to B.1.617.2 becoming the prevailing variant in the UK.
4 Jun, 2021 | 10:36h | UTCRelated: Covid: Indian variant ‘now dominant’ in the UK – BBC
After COVID-19 successes, researchers push to develop mRNA vaccines for other infectious diseases and cancer.
2 Jun, 2021 | 08:34h | UTC
What scientists know about new, fast-spreading coronavirus variants.
26 May, 2021 | 08:45h | UTCWhat scientists know about new, fast-spreading coronavirus variants – Nature
A ‘more rapidly spreading virus’ (B.1.617 variant) is fueling India’s mega COVID-19 surge, WHO chief scientist says
11 May, 2021 | 09:16h | UTCSee also: WHO Upgrades Virus Mutation Driving India’s COVID Surge To ‘Variant of Concern’ – Global Cases Start To ‘Plateau’ – Health Policy Watch AND Why India needs oxygen more urgently than vaccines – Vox AND WHO names B1617 fourth COVID-19 variant of concern – CIDRAP
Case-control study shows an increased risk of colorectal cancer in first degree relatives of patients with colorectal polyps.
10 May, 2021 | 00:50h | UTCCommentaries: Intestinal polyps in close relatives can increase risk of colorectal cancer – Karolinska Institutet AND Relatives’ Colonoscopy Results Could Affect Your Colon Cancer Risk – HealthDay
Commentary on Twitter
After adjusting for family history of colorectal cancer, siblings and children of patients with colorectal polyps were found to be at increased risk of colorectal cancer in this study #BMJResearch https://t.co/E30VDw3PqT
— The BMJ (@bmj_latest) May 9, 2021
Study on five million Swedes finds links between blood groups and disease risks
3 May, 2021 | 05:09h | UTCNews Release: Study on five million Swedes finds links between blood groups and disease risks – Karolinska Institutet
Original Study: An agnostic study of associations between ABO and RhD blood group and phenome-wide disease risk – eLife
One million coronavirus sequences: popular genome site hits mega milestone
25 Apr, 2021 | 21:59h | UTCOne million coronavirus sequences: popular genome site hits mega milestone – Nature
How mRNA Technology Could Change the World
5 Apr, 2021 | 01:36h | UTCHow mRNA Technology Could Change the World – The Atlantic (a few articles per month are free)
RCT: Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
5 Apr, 2021 | 01:01h | UTCLumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1 – New England Journal of Medicine (link to abstract – $ for full-text)
Another study indicates SARS-CoV-2 variant B.1.351, but not variant B.1.1.7, has partial resistance to neutralizing antibodies generated by natural infection or mRNA vaccination
28 Mar, 2021 | 22:53h | UTC
Commentaries on Twitter
Now a peer-reviewed pub in a top journal, this elegant study clearly shows that variant B.1.351 isn't stopped by antibodies from prior infection or the Pfizer vax. We'll have revised vaccines, but we don't yet. Please behave accordingly. https://t.co/w8GHPDB7aL
— EQV Analytics (@AnalyticsEqv) March 27, 2021
New @NatureMedicine, further data on immune response after vaccination to 2 variants, B.1.1.7 (UK) and B.1.351 (SA). Reinforcing recent reports, the latter is more of an immune evader, and may pose vulnerability for reinfection post-vaccinehttps://t.co/w8xFc3fkh5 pic.twitter.com/i7DAnjSZwE
— Eric Topol (@EricTopol) March 26, 2021
Opinion | The Coronavirus Variants Don’t Seem to Be Highly Variable So Far
28 Mar, 2021 | 22:46h | UTCThe Coronavirus Variants Don’t Seem to Be Highly Variable So Far – Scientific American
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age
14 Mar, 2021 | 20:07h | UTC70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age – The Lancet Oncology (link to abstract – $ for full-text)
Position Statement: The Role of Pharmacogenomics in Contemporary Cardiovascular Therapy
11 Mar, 2021 | 07:53h | UTC
Clinical practice guidelines for BRCA1 and BRCA2 genetic testing
21 Feb, 2021 | 21:43h | UTCClinical practice guidelines for BRCA1 and BRCA2 genetic testing – European Journal of Cancer
Commentary on Twitter
BRCA1 and BRCA2 genetic testing- Clinical practice guidelineshttps://t.co/bpdXf70PnW pic.twitter.com/i6O0br35ap
— K Pavithran (@drkpavithran) February 15, 2021
BRUGADA-RISK: A primary prevention clinical risk score model for patients with Brugada Syndrome
18 Feb, 2021 | 02:57h | UTCCommentary: Risk Score Model for Brugada Syndrome – American College of Cardiology
Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women
10 Feb, 2021 | 01:07h | UTC
A population-based study of genes previously implicated in breast cancer
10 Feb, 2021 | 01:05h | UTCA Population-Based Study of Genes Previously Implicated in Breast Cancer – New England Journal of Medicine (link to abstract – $ for full-text)
Consensus recommendations: Diagnosis and management of Bartter syndrome
3 Feb, 2021 | 01:04h | UTC
How Covid-19 mutations are changing the pandemic
29 Jan, 2021 | 01:55h | UTCHow Covid-19 mutations are changing the pandemic – BBC
NCCN Guideline: Genetic/familial high-risk assessment: breast, ovarian, and pancreatic
14 Jan, 2021 | 01:28h | UTC